Dobutamine stress cardiac magnetic resonance versus echocardiography for the assessment of outcome in patients with suspected or known coronary artery disease. Are the two imaging modalities comparable?

International Journal of Cardiology

Volumn 171, Issue 2, 2014, Pages 153-160

  Bikiri, Eleni ^a   Mereles, Derliz ^a   Voss, Andreas ^a   Greiner, Sebastian ^a   Hess, Alexander ^a   Buss, Sebastian J ^a   Hofmann, Nina P ^a   Giannitsis, Evangelos ^a   Katus, Hugo A ^a   Korosoglou, Grigorios ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

Cardiac magnetic resonance; Coronary artery disease; Echocardiography; High dose dobutamine stress testing; Wall motion analysis

Indexed keywords

DOBUTAMINE;

AGE; AGED; ARTICLE; CARDIOVASCULAR MAGNETIC RESONANCE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DIABETES MELLITUS; DOBUTAMINE CARDIAC MAGNETIC RESONANCE; DOBUTAMINE STRESS ECHOCARDIOGRAPHY; FEMALE; GENDER; HEART DEATH; HEART INFARCTION; HEART MUSCLE ISCHEMIA; HIGH RISK PATIENT; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE SCANNER; OUTCOME ASSESSMENT; PHARMACOLOGIC STRESS TESTING; PREDICTIVE VALUE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR; STRESS ECHOCARDIOGRAPHY; ULTRASOUND SCANNER;

CARDIAC MAGNETIC RESONANCE; CORONARY ARTERY DISEASE; ECHOCARDIOGRAPHY; HIGH-DOSE DOBUTAMINE STRESS TESTING; WALL MOTION ANALYSIS;

AGED; CARDIAC IMAGING TECHNIQUES; CARDIOTONIC AGENTS; CORONARY ARTERY DISEASE; DEATH; DOBUTAMINE; ECHOCARDIOGRAPHY, STRESS; EXERCISE TEST; FEMALE; FOLLOW-UP STUDIES; HUMANS; MAGNETIC RESONANCE IMAGING, CINE; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PREDICTIVE VALUE OF TESTS; RETROSPECTIVE STUDIES; RISK ASSESSMENT;

EID: 84892877164     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2013.11.038     Document Type: Article

References (53)

1. I. Afridi, M.A. Quinones, W.A. Zoghbi, and J. Cheirif Dobutamine stress echocardiography: sensitivity, specificity, and predictive value for future cardiac events Am Heart J 127 6 1994 1510 1515
2. L.P. Anthopoulos, M.S. Bonou, and F.G. Kardaras et al. Stress echocardiography in elderly patients with coronary artery disease: applicability, safety and prognostic value of dobutamine and adenosine echocardiography in elderly patients J Am Coll Cardiol 28 1 1996 52 59
3. S.C. Chuah, P.A. Pellikka, V.L. Roger, R.B. McCully, and J.B. Seward Role of dobutamine stress echocardiography in predicting outcome in 860 patients with known or suspected coronary artery disease Circulation 97 15 1998 1474 1480
4. M.L. Geleijnse, P.M. Fioretti, and J.R. Roelandt Methodology, feasibility, safety and diagnostic accuracy of dobutamine stress echocardiography J Am Coll Cardiol 30 3 1997 595 606
5. R. Gebker, C. Jahnke, and R. Manka et al. The role of dobutamine stress cardiovascular magnetic resonance in the clinical management of patients with suspected and known coronary artery disease J Cardiovasc Magn Reson 13 2011 46
6. W.G. Hundley, T.M. Morgan, C.M. Neagle, C.A. Hamilton, P. Rerkpattanapipat, and K.M. Link Magnetic resonance imaging determination of cardiac prognosis Circulation 106 18 2002 2328 2333
7. S. Kelle, A. Chiribiri, and J. Vierecke et al. Long-term prognostic value of dobutamine stress CMR JACC Cardiovasc Imaging 4 2 2011 161 172
8. D. Kuijpers, K.Y. Ho, P.R. van Dijkman, R. Vliegenthart, and M. Oudkerk Dobutamine cardiovascular magnetic resonance for the detection of myocardial ischemia with the use of myocardial tagging Circulation 107 12 2003 1592 1597
9. E. Nagel, H.B. Lehmkuhl, and W. Bocksch et al. Noninvasive diagnosis of ischemia-induced wall motion abnormalities with the use of high-dose dobutamine stress MRI: comparison with dobutamine stress echocardiography Circulation 99 6 1999 763 770
10. I. Paetsch, C. Jahnke, and A. Wahl et al. Comparison of dobutamine stress magnetic resonance, adenosine stress magnetic resonance, and adenosine stress magnetic resonance perfusion Circulation 110 7 2004 835 842
11. R. Gebker, C. Jahnke, and R. Manka et al. High spatial resolution myocardial perfusion imaging during high dose dobutamine/atropine stress magnetic resonance using k-t SENSE Int J Cardiol 158 3 2012 411 416
12. J.H. Lee, D.H. Yang, and W.S. Choi et al. Prediction of improvement in cardiac function by high dose dobutamine stress echocardiography in patients with recent onset idiopathic dilated cardiomyopathy Int J Cardiol 167 4 2013 1649 1650
13. A. Pingitore, G.D. Aquaro, and V. Lorenzoni et al. Influence of preload and afterload on stroke volume response to low-dose dobutamine stress in patients with non-ischemic heart failure: a cardiac MR study Int J Cardiol 166 2 2013 475 481
14. I.A. Paraskevaidis, I. Ikonomidis, and J. Parissis et al. Dobutamine-induced changes of left atrial two-dimensional deformation predict clinical and neurohumoral improvement after levosimendan treatment in patients with acutely decompensated chronic heart failure Int J Cardiol 157 1 2012 31 37
15. V. Parish, I. Valverde, and S. Kutty et al. Dobutamine stress MRI in repaired tetralogy of Fallot with chronic pulmonary regurgitation: a comparison with healthy volunteers Int J Cardiol 166 1 2013 96 105
16. R.W. Nesto, and G.J. Kowalchuk The ischemic cascade: temporal sequence of hemodynamic, electrocardiographic and symptomatic expressions of ischemia Am J Cardiol 59 7 1987 23C 30C
17. C. Jahnke, E. Nagel, and R. Gebker et al. Prognostic value of cardiac magnetic resonance stress tests: adenosine stress perfusion and dobutamine stress wall motion imaging Circulation 115 13 2007 1769 1776
18. T.H. Marwick, C. Case, and S. Sawada et al. Prediction of mortality using dobutamine echocardiography J Am Coll Cardiol 37 3 2001 754 760
19. D. Poldermans, P.M. Fioretti, and E. Boersma et al. Long-term prognostic value of dobutamine-atropine stress echocardiography in 1737 patients with known or suspected coronary artery disease: a single-center experience Circulation 99 6 1999 757 762
20. K.R. Nandalur, B.A. Dwamena, A.F. Choudhri, M.R. Nandalur, and R.C. Carlos Diagnostic performance of stress cardiac magnetic resonance imaging in the detection of coronary artery disease: a meta-analysis J Am Coll Cardiol 50 14 2007 1343 1353
21. E. Picano, S. Molinaro, and E. Pasanisi The diagnostic accuracy of pharmacological stress echocardiography for the assessment of coronary artery disease: a meta-analysis Cardiovasc Ultrasound 6 2008 30
22. M.L. Geleijnse, B.J. Krenning, and B.M. van Dalen et al. Factors affecting sensitivity and specificity of diagnostic testing: dobutamine stress echocardiography J Am Soc Echocardiogr 22 11 2009 1199 1208
23. M.D. Cerqueira, N.J. Weissman, and V. Dilsizian et al. Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart: a statement for healthcare professionals from the Cardiac Imaging Committee of the Council on Clinical Cardiology of the American Heart Association Circulation 105 4 2002 539 542
24. G. Korosoglou, A.E. Dubart, and K.G. DaSilva Jr. et al. Real-time myocardial perfusion imaging for pharmacologic stress testing: added value to single photon emission computed tomography Am Heart J 151 1 2006 131 138
25. G. Korosoglou, A. Hansen, and J. Hoffend et al. Comparison of real-time myocardial contrast echocardiography for the assessment of myocardial viability with fluorodeoxyglucose-18 positron emission tomography and dobutamine stress echocardiography Am J Cardiol 94 5 2004 570 576
26. G. Korosoglou, K.G. da Silva Jr., and N. Labadze et al. Real-time myocardial contrast echocardiography for pharmacologic stress testing: is quantitative estimation of myocardial blood flow reserve necessary? J Am Soc Echocardiogr 17 1 2004 1 9
27. G. Montalescot, U. Sechtem, and S. Achenbach et al. 2013 ESC guidelines on the management of stable coronary artery disease: The Task Force on the management of stable coronary artery disease of the European Society of Cardiology Eur Heart J 34 38 2013 2949 3003
28. M.S. Kramer, and A.R. Feinstein Clinical biostatistics. LIV. The biostatistics of concordance Clin Pharmacol Ther 29 1 1981 111 123
29. R. Hoffmann, H. Lethen, and T. Marwick et al. Analysis of interinstitutional observer agreement in interpretation of dobutamine stress echocardiograms J Am Coll Cardiol 27 2 1996 330 336
30. E. Picano, F. Lattanzi, A. Orlandini, C. Marini, and A. L'Abbate Stress echocardiography and the human factor: the importance of being expert J Am Coll Cardiol 17 3 1991 666 669
31. A. Pingitore, E. Picano, and A. Varga et al. Prognostic value of pharmacological stress echocardiography in patients with known or suspected coronary artery disease: a prospective, large-scale, multicenter, head-to-head comparison between dipyridamole and dobutamine test. Echo-Persantine International Cooperative (EPIC) and Echo-Dobutamine International Cooperative (EDIC) Study Groups J Am Coll Cardiol 34 6 1999 1769 1777
32. R. Sicari, E. Picano, and P. Landi et al. Prognostic value of dobutamine-atropine stress echocardiography early after acute myocardial infarction. Echo Dobutamine International Cooperative (EDIC) Study J Am Coll Cardiol 29 2 1997 254 260
33. E. Picano, P. Landi, and L. Bolognese et al. Prognostic value of dipyridamole echocardiography early after uncomplicated myocardial infarction: a large-scale, multicenter trial. The EPIC Study Group Am J Med 95 6 1993 608 618
34. N.G. Bellenger, L.C. Davies, J.M. Francis, A.J. Coats, and D.J. Pennell Reduction in sample size for studies of remodeling in heart failure by the use of cardiovascular magnetic resonance J Cardiovasc Magn Reson 2 4 2000 271 278
35. I. Paetsch, C. Jahnke, and V.A. Ferrari et al. Determination of interobserver variability for identifying inducible left ventricular wall motion abnormalities during dobutamine stress magnetic resonance imaging Eur Heart J 27 12 2006 1459 1464
36. H. Thiele, M.J. Kappl, S. Conradi, J. Niebauer, R. Hambrecht, and G. Schuler Reproducibility of chronic and acute infarct size measurement by delayed enhancement-magnetic resonance imaging J Am Coll Cardiol 47 8 2006 1641 1645
37. E.H. Steinberg, L. Madmon, C.P. Patel, S.P. Sedlis, I. Kronzon, and J.L. Cohen Long-term prognostic significance of dobutamine echocardiography in patients with suspected coronary artery disease: results of a 5-year follow-up study J Am Coll Cardiol 29 5 1997 969 973
38. S.S. Yao, E. Qureshi, M.V. Sherrid, and F.A. Chaudhry Practical applications in stress echocardiography: risk stratification and prognosis in patients with known or suspected ischemic heart disease J Am Coll Cardiol 42 6 2003 1084 1090
39. E. Biagini, A. Elhendy, and J.J. Bax et al. Seven-year follow-up after dobutamine stress echocardiography: impact of gender on prognosis J Am Coll Cardiol 45 1 2005 93 97
40. C. Bjork Ingul, E. Rozis, S.A. Slordahl, and T.H. Marwick Incremental value of strain rate imaging to wall motion analysis for prediction of outcome in patients undergoing dobutamine stress echocardiography Circulation 115 10 2007 1252 1259
41. L.J. Shaw, C. Vasey, S. Sawada, C. Rimmerman, and T.H. Marwick Impact of gender on risk stratification by exercise and dobutamine stress echocardiography: long-term mortality in 4234 women and 6898 men Eur Heart J 26 5 2005 447 456
42. R. Sicari, E. Pasanisi, L. Venneri, P. Landi, L. Cortigiani, and E. Picano Stress echo results predict mortality: a large-scale multicenter prospective international study J Am Coll Cardiol 41 4 2003 589 595
43. F.B. Sozzi, A. Elhendy, and J.R. Roelandt et al. Prognostic value of dobutamine stress echocardiography in patients with diabetes Diabetes Care 26 4 2003 1074 1078
44. N. Chaowalit, R.B. McCully, M.J. Callahan, F. Mookadam, K.R. Bailey, and P.A. Pellikka Outcomes after normal dobutamine stress echocardiography and predictors of adverse events: long-term follow-up of 3014 patients Eur Heart J 27 24 2006 3039 3044
45. D. Kuijpers, P.R. van Dijkman, C.H. Janssen, R. Vliegenthart, F. Zijlstra, and M. Oudkerk Dobutamine stress MRI. Part II. Risk stratification with dobutamine cardiovascular magnetic resonance in patients suspected of myocardial ischemia Eur Radiol 14 11 2004 2046 2052
46. G. Korosoglou, Y. Elhmidi, and H. Steen et al. Prognostic value of high-dose dobutamine stress magnetic resonance imaging in 1,493 consecutive patients: assessment of myocardial wall motion and perfusion J Am Coll Cardiol 56 15 2010 1225 1234
47. C. Jahnke, V. Furundzija, and R. Gebker et al. Gender-based prognostic value of pharmacological cardiac magnetic resonance stress testing: head-to-head comparison of adenosine perfusion and dobutamine wall motion imaging JACC Cardiovasc Imaging 1 2 2008 145 152
48. S. Kelle, E. Nagel, and A. Voss et al. A bi-center cardiovascular magnetic resonance prognosis study focusing on dobutamine wall motion and late gadolinium enhancement in 3,138 consecutive patients J Am Coll Cardiol 61 22 2013 2310 2312
49. J.C. Plana, I.A. Mikati, and H. Dokainish et al. A randomized cross-over study for evaluation of the effect of image optimization with contrast on the diagnostic accuracy of dobutamine echocardiography in coronary artery disease The OPTIMIZE Trial JACC Cardiovasc Imaging 1 2 2008 145 152
50. S. Mandapaka, and W.G. Hundley Dobutamine cardiovascular magnetic resonance: a review J Magn Reson Imaging 24 3 2006 499 512
51. D.J. Pennell, U.P. Sechtem, and C.B. Higgins et al. Clinical indications for cardiovascular magnetic resonance (CMR): Consensus Panel report Eur Heart J 25 21 2004 1940 1965
52. H. von Bibra, A. Tuchnitz, A. Klein, J. Schneider-Eicke, A. Schomig, and M. Schwaiger Regional diastolic function by pulsed Doppler myocardial mapping for the detection of left ventricular ischemia during pharmacologic stress testing: a comparison with stress echocardiography and perfusion scintigraphy J Am Coll Cardiol 36 2 2000 444 452
53. I. Paetsch, D. Foll, and A. Kaluza et al. Magnetic resonance stress tagging in ischemic heart disease Am J Physiol Heart Circ Physiol 288 6 2005 H2708 H2714